Norbert Weißmann

Active 1995–2025

Also published as
Norbert Weissmann
152
Papers
20,633
Citations
86
h-index
149
i10-index

Citations

Citations per year for Norbert Weißmann1960: 2 citations1986: 1 citations1993: 1 citations1996: 1 citations1997: 1 citations1998: 3 citations1999: 2 citations2000: 3 citations2001: 6 citations2002: 12 citations2003: 48 citations2004: 84 citations2005: 107 citations2006: 130 citations2007: 139 citations2008: 190 citations2009: 171 citations2010: 178 citations2011: 164 citations2012: 225 citations2013: 268 citations2014: 237 citations2015: 216 citations2016: 190 citations2017: 186 citations2018: 212 citations2019: 634 citations2020: 782 citations2021: 740 citations2022: 691 citations2023: 454 citations2024: 685 citations2025: 331 citations2026: 6 citations1961–1985: no citations, so these years are not shown1987–1992: no citations, so these years are not shown1994–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,084 citing papers, 24% of this breakdownChina: 1,201 citing papers, 13.9% of this breakdownGermany: 854 citing papers, 9.8% of this breakdownUnited Kingdom: 669 citing papers, 7.7% of this breakdownFrance: 321 citing papers, 3.7% of this breakdownItaly: 299 citing papers, 3.5% of this breakdownCanada: 290 citing papers, 3.3% of this breakdownNetherlands: 219 citing papers, 2.5% of this breakdownSpain: 208 citing papers, 2.4% of this breakdownJapan: 205 citing papers, 2.4% of this breakdownAustralia: 196 citing papers, 2.3% of this breakdownSwitzerland: 167 citing papers, 1.9% of this breakdown
0%24%Other 22.6%

Fields

  • Medicine58.8%
  • Biochemistry, Genetics and Molecular Biology24.9%
  • Immunology and Microbiology7.2%
  • Neuroscience4.9%
  • Nursing1.2%
  • Environmental Science0.6%
  • Other2.4%

Topics

  • Pulmonary Hypertension Research and Treatments10.2%
  • Nitric Oxide and Endothelin Effects4.7%
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms2.9%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis2.3%
  • Chronic Obstructive Pulmonary Disease (COPD) Research2.2%
  • Mitochondrial Function and Pathology2%
  • Other75.7%

Coauthors

All papers

Open in search
  1. Pulmonary hypertension in chronic lung disease and hypoxia

    Authors: , , , , , , , , , , , - European Respiratory Journal 2018 cited by 761

  2. Nox family NADPH oxidases: Molecular mechanisms of activation

    Authors: , , - Free Radical Biology and Medicine 2014 cited by 666

  3. Hypoxia-inducible factor signaling in pulmonary hypertension

    Authors: , , , , - Journal of Clinical Investigation 2020 cited by 224

  4. Pulmonary Hypertension: A Contemporary Review

    Authors: , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 cited by 167

  5. Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2012 cited by 409

  6. The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups

    Authors: , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2017 cited by 311

  7. Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase

    Authors: , , , , , , , , , , , , - Circulation Research 2012 cited by 614

  8. Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Biology 2010 cited by 438

  9. Cellular and Molecular Basis of Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2009 cited by 812

  10. Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension

    Authors: , , , , , , , , , , , - Nature Medicine 2014 cited by 279

  11. Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2018 cited by 91

  12. Targeting Jak–Stat Signaling in Experimental Pulmonary Hypertension

    Authors: , , , , , , , , , , , , - American Journal of Respiratory Cell and Molecular Biology 2020 cited by 80

  13. TRPV4 channels are essential for alveolar epithelial barrier function as protection from lung edema

    Authors: , , , , , , , , , , , , - JCI Insight 2020 cited by 69

  14. Bypassing mitochondrial complex III using alternative oxidase inhibits acute pulmonary oxygen sensing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2020 cited by 66

  15. Pulmonary hypertension in chronic obstructive pulmonary disease

    Authors: , , , , , , , - British Journal of Pharmacology 2020 cited by 98

  16. Acute O 2 sensing through HIF2α-dependent expression of atypical cytochrome oxidase subunits in arterial chemoreceptors

    Authors: , , , , , , , , , , , - Science Signaling 2020 cited by 93

  17. Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target

    Authors: , , , , , , , , , - Frontiers in Cardiovascular Medicine 2021 cited by 87

  18. Interactions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and Thiols

    Authors: , , , - Journal of Biological Chemistry 2003 cited by 681

  19. Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2011 cited by 352

  20. Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2

    Authors: , , , , , , - Nucleic Acids Research 2013 cited by 188

  21. SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2022 cited by 55

  22. Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ralf P. Brandes - Circulation 2017 cited by 242

  23. Pathophysiology and Treatment of High-Altitude Pulmonary Vascular Disease

    Authors: , , , , - Circulation 2015 cited by 158

  24. A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension

    Authors: , , , , , , , , , , , , , , - Nature Communications 2019 cited by 103